ECT is comprised of two primary services, Protocol+ for the registration of trials and Results Services for the publications of trial results.
EveryClinicalTrial (ECT), a service to address the registration and trial results requirements of ClinicalTrials.gov, is now available. ECT is comprised of two primary services, Protocol+ for the registration of trials and Results Services for the publications of trial results, and takes advantage of the company’s translational tools that offer efficiencies for uploading protocols to the site. The company predicts the service will be beneficial for all sponsors and institutions, but for those who only have a few trials a year, it offers a low-cost solution for a convoluted process. ECT Founder Colin Miller is formerly with BioClinica.
Read the full release.
Including Women of Childbearing Age in Clinical Research
March 26th 2024In recognition of International Women's Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and Marie Teil, Global Head of UCB’s Women of Childbearing Age Program. They speak about the specific challenges women with chronic illnesses face when accessing appropriate treatment and participating in clinical trials, UCB's Women of Childbearing Age Program and it’s most successful strategies, and much more.
Using Patient Reported Outcomes in Dermatology Trials
April 25th 2024In part 3 of this video interview with ACT editor Andy Studna, Melissa Mooney, director, eCOA sales engineering, IQVIA sheds light on the unique challenges of dermatology trials and how clinical outcome assessments can be implemented in them.
Improving Engagement While Maintaining Data Integrity & Validity
March 19th 2024In recognition of Women's Health Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and uMotif's Chief Product Officer, Julia Lakeland, discuss new technologies improving patient engagement and reducing the emotional and logistical burdens of participation, ethical considerations that should be addressed when implementing those technologies, while ensuring patient privacy, and much more.